WO2020151261A1 - Cotton-like fiber scaffold as well as preparation method therefor and application thereof - Google Patents

Cotton-like fiber scaffold as well as preparation method therefor and application thereof Download PDF

Info

Publication number
WO2020151261A1
WO2020151261A1 PCT/CN2019/110974 CN2019110974W WO2020151261A1 WO 2020151261 A1 WO2020151261 A1 WO 2020151261A1 CN 2019110974 W CN2019110974 W CN 2019110974W WO 2020151261 A1 WO2020151261 A1 WO 2020151261A1
Authority
WO
WIPO (PCT)
Prior art keywords
cotton
fiber
fiber scaffold
bioglass
spinning
Prior art date
Application number
PCT/CN2019/110974
Other languages
French (fr)
Chinese (zh)
Inventor
李子樵
周杰
徐嘉麟
Original Assignee
蓝怡科技集团股份有限公司
浙江蓝怡医药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 蓝怡科技集团股份有限公司, 浙江蓝怡医药有限公司 filed Critical 蓝怡科技集团股份有限公司
Publication of WO2020151261A1 publication Critical patent/WO2020151261A1/en

Links

Images

Classifications

    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/4382Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0061Electro-spinning characterised by the electro-spinning apparatus
    • D01D5/0092Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/10Other agents for modifying properties
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/88Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/92Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyesters
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/76Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres otherwise than in a plane, e.g. in a tubular way
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/12Materials or treatment for tissue regeneration for dental implants or prostheses

Definitions

  • This application belongs to the field of biomedical composite materials, and in particular relates to a cotton-like fiber scaffold and its preparation method and application.
  • the existing bone repair materials mainly include autogenous bone , Allogeneic bone and artificial bone substitutes.
  • Autologous bone has the problem of inconvenience and limited sources.
  • Allogeneic bone has tissue incompatibility and rejection.
  • Artificial bone substitutes are plastic, histocompatibility, and biodegradability.
  • Electrospinning is a commonly used method for preparing fiber filaments.
  • the size of the fibers obtained by electrospinning is of nanometer or submicron level. It has the advantages of large specific surface area, high porosity, and good spatial connectivity, so it is often used Used in the field of biological tissue engineering. In bone repair, electrospun fiber has considerable advantages. Its excellent flexibility can be suitable for bone defects of various shapes and fully fill the defect.
  • the ultra-high specific surface area and porosity are conducive to the migration of osteoblasts in large numbers. In addition, its ultra-high porosity and good connectivity can not only facilitate the migration of osteoblasts, but also promote the formation of blood vessels and the transportation of nutrients. .
  • bioactive materials are also a research hotspot, especially materials such as bioglass and ⁇ -tricalcium phosphate ( ⁇ -TCP). Due to their good biocompatibility, bioactivity and osteoconductivity, they can be It produces hydroxyapatite which is very similar to the composition of bone tissue and has excellent biodegradability.
  • the elements such as Ca and P produced by degradation in the body can participate in and promote the formation of new bone in the body. It is a relatively mature Osteogenic material.
  • Polylactic acid (PLLA) material has good biocompatibility, biodegradability and mechanical properties, and has the advantages of easy processing. It is also a hot material in the field of bone tissue repair, but its disadvantages are poor biological activity and lack of osteogenic ability. Therefore, using electrospinning technology to synthesize bioactive ceramic particles and polylactic acid to prepare a composite material, theoretically, an active bone repair material with excellent mechanical and biological properties can be obtained.
  • CN106983910A discloses a method for preparing a polylactic acid composite bioglass tissue repair material, which dissolves polylactic acid particles in chloroform to obtain a polylactic acid solution, and then combines polyethylene oxide-polypropylene oxide- Polyethylene oxide triblock polymer is dissolved in ethanol, and ethyl silicate, triethyl phosphate, calcium nitrate, hydrochloric acid and other components are added to it to obtain a mixed liquid. The polylactic acid solution is mixed and electrospinning is performed to obtain the polylactic acid composite bioglass tissue repair material.
  • most of the materials obtained are film-like materials.
  • the process of preparing bioglass by sol-gel method and re-spinning does not undergo a heat treatment step, which may cause a large amount of organic impurities in the product.
  • the human body has a toxic effect, and the obtained bone implant material is of a fixed shape. It requires post-processing before the operation and the operation is cumbersome. After implantation, there will be a certain gap at the seam, making the implant material unable to contact the host bone , Thereby reducing the speed of bone repair.
  • the purpose of this application is to provide a biological bone material with high biological activity that can adapt to various bone defects and an efficient, convenient, and environmentally friendly preparation method, so that it has a similar cotton
  • the high compressibility and high resilience of the product can perfectly adapt to various bone defect shapes and realize the repair of damaged bones or teeth and other hard tissues.
  • one of the objectives of the present application is to provide a cotton-like fiber scaffold, the cotton-like fiber scaffold comprising a composite fiber obtained by blending a bioactive material with polylactic acid and spinning the composite fiber.
  • the obtained fiber scaffold has the compressibility and higher compression recovery rate like cotton.
  • the bioactive material includes any one of bioglass, ⁇ -tricalcium phosphate and calcium sulfate or a mixture of at least two materials.
  • the cotton-like fiber scaffold obtained by using the above-mentioned biologically active material in this application combines the biocompatibility and degradability of the biologically active material with the excellent mechanical properties of polylactic acid material, its cotton-like appearance and sufficient compressibility to make it in After being implanted in the body, it can perfectly adapt to various bone defect shapes, produce osteogenic elements during the degradation process, promote the generation of osteogenic factors, and achieve the repair of damaged bones or teeth and other hard tissues.
  • the weight ratio of the bioactive material to the polylactic acid is 0.4 to 1.5:1, for example, 0.45:1, 0.50:1, 0.55:1, 0.60:1, 0.65:1, 0.70:1 , 0.75:1, 0.80:1, 0.85:1, 0.90:1, 0.95:1, 1.00:1, 1.05:1, 1.10:1, 1.15:1, 1.20:1, 1.25:1, 1.30:1, 1.35 : 1, 1.4:1 or 1.45:1, etc.
  • the obtained composite fiber has better mechanical properties, compressibility, recovery performance, biological activity, degradation performance and biocompatibility, and is more preferably 0.65 ⁇ 1:1.
  • the bioactive material is bioglass.
  • the bioglass is a bioglass containing silica, calcium oxide, phosphorus pentoxide and additives, and the additives are any of sodium oxide, potassium oxide, magnesium oxide, aluminum oxide, and calcium fluoride. One or a mixture of at least two.
  • the bioglass is any one or a mixture of at least two of 45S5 type, AW type, Bioverit type, Ceravital type and 58S type bioglass.
  • the biological glass is ball-milled and has a particle size of 0.5-30 ⁇ m, such as 0.6 ⁇ m, 0.8 ⁇ m, 1.2 ⁇ m, 2 ⁇ m, 4 ⁇ m, 6 ⁇ m, 8 ⁇ m, 10 ⁇ m, 12 ⁇ m, 14 ⁇ m, 16 ⁇ m, 18 ⁇ m, 20 ⁇ m, 22 ⁇ m. , 24 ⁇ m, 26 ⁇ m, 28 ⁇ m or 29 ⁇ m, etc.
  • the bioglass in the above particle size range has excellent spinning and fiberizing ability. If the particle size of the bioglass is too high, it is difficult to fiberize, and the particle size is too low, which will easily cause the bioglass to spin The obtained composite fiber is unevenly distributed, which reduces the mechanical properties and degradation performance of the composite fiber.
  • the diameter of the composite fibers is 1-50 ⁇ m, for example, 2 ⁇ m, 4 ⁇ m. , 6 ⁇ m, 10 ⁇ m, 15 ⁇ m, 20 ⁇ m, 25 ⁇ m, 30 ⁇ m, 35 ⁇ m, 40 ⁇ m, 45 ⁇ m or 48 ⁇ m etc.
  • the number average molecular weight of the polylactic acid is 100,000 to 1,000,000, such as 105,000, 125,000, 150,000, 200,000, 250,000, 300,000, 350,000, 400000, 450,000, 500,000, 550,000, 600000, 650,000, 700000, 750,000, 800000, 850,000, 900,000, 950,000 or 980000, etc.
  • the second objective of the present application is to provide a method for preparing the cotton-like fiber scaffold, which includes the following steps:
  • Step (1) mixing the bioactive material with polylactic acid, and dissolving the mixture with an organic solvent to obtain a spinning dope;
  • Step (2) Electrospin the spinning dope obtained in step (1) using an electrostatic spinning device, and collect the electrostatic spinning product with alcohol;
  • Step (3) Take out the coagulated composite fiber filaments in the alcohol of step (2), and dry them to obtain the cotton-like fiber scaffold.
  • the organic solvent described in step (1) is chloroform.
  • the content of polylactic acid in the spinning dope described in step (1) is 8-14% by weight, such as 8.5% by weight, 9% by weight, 9.5% by weight, 10% by weight, 10.5% by weight, 11wt%, 11.5wt%, 12wt%, 12.5%, 13wt%, 13.5wt% or 13.8wt%, etc.
  • the extrusion speed of the spinning dope in the electrospinning equipment is 0.05 to 0.4 mL/min, for example, 0.08 mL/min, 0.1 mL/min, 0.13 mL /min, 0.15mL/min, 0.18mL/min, 0.20mL/min, 0.25mL/min, 0.30mL/min, 0.35mL/min or 0.38mL/min, etc.
  • the voltage of the electrospinning in step (2) is 10-30kV, such as 12kV, 14kV, 16kV, 18kV, 20kV, 22kV, 24kV, 26kV or 28kV.
  • the distance between the spinning nozzle and the spinning receiving device is 5-30 cm, for example, 6 cm, 8 cm, 10 cm, 12 cm, 14 cm, 16 cm, 18 cm, 20cm, 22cm, 24cm, 26cm or 28cm, etc.
  • the alcohol mentioned in step (2) is ethanol.
  • the drying described in step (3) is performed in a fume hood.
  • the drying temperature in step (3) is room temperature, and the drying time is 24-48h, such as 25h, 27h, 29h, 31h, 33h, 35h, 37h, 39h, 41h, 43h, 45h or 47h, etc. .
  • the preparation method includes the following steps:
  • Step (1) The bioglass is mixed with ethanol, the mixture is ball milled, dried and sieved to obtain a pretreated bioglass with a particle size of 0.5-30 ⁇ m, and then the pretreated bioglass and polylactic acid are weighted Mix at a ratio of 0.4 to 1.5:1, and dissolve the mixture with chloroform to obtain a spinning dope with a polylactic acid content of 8 to 14 wt%;
  • Step (2) Inject the spinning stock solution obtained in step (1) into the syringe of the electrospinning equipment, control the voltage of the electrospinning equipment to 10-30kV, and extrude the syringe at an extrusion speed of 0.05-0.4mL/min
  • the spinning dope is output, the distance between the spinning nozzle and the spinning receiving device is 5-30cm, and the spinning receiving device is filled with absolute ethanol to collect the product of electrospinning;
  • Step (3) Take out the composite fiber filaments coagulated in absolute ethanol in the spinning receiving equipment collected in step (2), transfer them to a fume hood, and dry them at room temperature for 24 to 48 hours.
  • the cotton-like fiber scaffold is obtained.
  • the third purpose of the present application is to provide an application of the cotton-like fiber scaffold in the field of bone repair or tooth hard tissue repair.
  • This application uses the method of electrospinning to obtain a highly adaptable cotton-like fiber scaffold with a compression rate of up to 45% and a recovery rate of up to 80%. Compared with the traditional drawing method, this The cotton-like fiber scaffold prepared by the application has a smaller fiber diameter, stronger flexibility, and higher porosity and specific surface area, which can provide more attachment points for osteoblasts, shorten the recovery time, and is suitable for various shapes The bone defect is completely repaired internally and on the surface.
  • the cotton-like fiber scaffold prepared in this application also has excellent biological activity, biocompatibility and biodegradability.
  • the inorganic part of it can be degraded in the body to produce calcium, phosphorus and other basic nutrients required for bone formation. Promote bone repair in the defect.
  • the organic part of polylactic acid has good degradability and biocompatibility. It will be degraded into lactic acid in the body, and then converted into carbon dioxide and water under the action of enzymes. Toxic side effects.
  • Figure 1 is a physical photo of the cotton-like fiber scaffold 1 obtained in Example 1 in the specific implementation of the application.
  • Figure 2 is a physical photo of the cotton-like fiber scaffold 2 obtained in Example 2 of the specific implementation of the application.
  • Figure 3 is a physical photo of the cotton-like fiber scaffold 3 obtained in Example 3 in the specific implementation of the application.
  • FIG. 4 is a physical photo of the cotton-like fiber scaffold 4 obtained in Example 4 in the specific embodiment of the application.
  • FIG. 5 is a physical photo of the cotton-like fiber scaffold 5 obtained in Example 5 in the specific embodiment of the application.
  • Fig. 6 is an SEM photograph of the cotton-like fiber scaffold 2 obtained in Example 2 in the specific embodiment of the application after the biological activity test.
  • Fig. 7 shows the XRD spectra of the cotton-like fiber scaffolds 1 to 3 obtained in Examples 1 to 3 in the specific embodiment of the application after the biological activity test.
  • Fig. 8 is a curve of the weight loss of the cotton-like fiber scaffolds 1 to 4 obtained in Examples 1 to 4 in the specific embodiments of the application in the degradation performance experiment over time.
  • the bioglass selected in this application is any one of 45S5, AW, Bioverit, Ceravital and 58S bioglasses or a mixture of at least two bioglasses.
  • the detailed components of each type of bioglass are as follows: Shown in Table 1.
  • Compression rate and recovery rate test Take 0.05g of the prepared cotton-like fiber scaffold and place it in a glass tube with an inner diameter of 22mm. Place a round glass cover (weight 1g) with the same diameter in the glass tube. On the cotton-like fiber support, measure the height from the bottom of the round glass cover to the bottom of the glass tube and record it as h 0. Then, place a 10g weight on the glass cover and let it stand for 30 minutes.
  • Fiber diameter test Use the JSM-2100F scanning electron microscope (SEM) produced by Rigaku Corporation to test the microscopic morphology of the cotton-like fiber scaffold, and calculate the average fiber diameter, and record it as the cotton-like fiber scaffold The diameter of the fiber.
  • SEM JSM-2100F scanning electron microscope
  • Step (1) Take 30g of 45S5 type bioglass and mix with 10mL of grinding liquid ethanol. The mixture is subjected to ball milling treatment to obtain a pretreated bioglass with a particle size of 15 ⁇ m. Then, the pretreated bioglass and 70g number average molecular weight 350,000 polylactic acid is mixed, and the mixture is dissolved in chloroform to obtain a spinning dope with a polylactic acid content of 12 wt%;
  • Step (2) Inject the spinning dope obtained in step (1) into the syringe of the electrostatic spinning equipment, control the voltage of the electrostatic spinning equipment to 20kV, and the syringe extrudes the spinning dope at an extrusion speed of 0.2mL/min , The distance between the spinning nozzle and the spinning receiving device is 20cm, and the spinning receiving device is filled with anhydrous ethanol to collect the products of electrospinning;
  • the cotton-like fiber scaffold 1 obtained in Example 1 has a compression rate of 35% and a recovery rate of 35% after testing, and the fiber diameter is 35 ⁇ m.
  • Example 1 The only difference from Example 1 is that the amount of bioglass added in step (1) is 40g, the amount of polylactic acid added is 60g, and the content of polylactic acid in the spinning dope is still 12wt%.
  • Example 1 The only difference from Example 1 is that the amount of bioglass added in step (1) is 50g, the amount of polylactic acid added is 50g, and the content of polylactic acid in the spinning dope is still 12wt%.
  • the compression rate was 40%, the recovery rate was 80%, and the fiber diameter was 40 ⁇ m.
  • Example 1 The only difference from Example 1 is that the amount of bioglass added in step (1) is 60g, the amount of polylactic acid added is 40g, and the content of polylactic acid in the spinning dope is still 12wt%.
  • the compression rate was 20%
  • the recovery rate was 60%
  • the fiber diameter was 44 ⁇ m.
  • Example 2 The only difference from Example 2 is that the bioglass in step (1) is replaced with ⁇ -tricalcium phosphate.
  • Example 5 a cotton-like fiber scaffold 5 was obtained. After testing, the compression rate was 40% and the recovery rate was 40%, and the fiber diameter was 42 ⁇ m.
  • Example 2 The only difference from Example 2 is that the bioglass in step (1) is replaced with calcium sulfate.
  • Example 6 a cotton-like fiber scaffold 6 was obtained.
  • the compression rate was 40% and the recovery rate was 45% after testing, and the fiber diameter was 38 ⁇ m.
  • Example 2 The only difference from Example 2 is that the bioglass in step (1) is replaced with a mixture of AW, Bioverit, and Ceravital bioglass at a weight ratio of 1:1:1.
  • the cotton-like fiber scaffold 7 was obtained in Example 7.
  • the compression rate was 44%, the recovery rate was 72%, and the fiber diameter was 40 ⁇ m.
  • the bioglass in step (1) is ball milled to obtain a pretreated bioglass with a particle size of 0.5 ⁇ m.
  • the voltage of the electrospinning equipment in step (2) is 10kV, and the syringe Extrude the spinning dope at an extrusion speed of 0.4mL/min, and the distance between the spinning nozzle and the spinning receiving device is 30cm,
  • the cotton-like fiber scaffold 8 was obtained in Example 8.
  • the compression rate was 35%, the recovery rate was 71%, and the fiber diameter was 2 ⁇ m.
  • the cotton-like fiber scaffold 9 is prepared by the following steps:
  • step (1) the bioglass in step (1) is ball milled to obtain pretreated bioglass with a particle size of 28 ⁇ m.
  • step (2) the voltage of the electrospinning equipment is 30kV, and the syringe is The extrusion speed of 0.08mL/min extrudes the spinning dope, and the distance between the spinning nozzle and the spinning receiving device is 5cm.
  • the cotton-like fiber scaffold 9 was obtained in Example 9.
  • the compression rate was 44%, the recovery rate was 55%, and the fiber diameter was 50 ⁇ m.
  • the cotton-like fiber scaffold 10 is prepared by the following steps:
  • Example 8 The only difference from Example 8 is that the bioglass in step (1) is ball milled to obtain a pretreated bioglass with a particle size of 0.1 ⁇ m.
  • the cotton-like fiber scaffold 10 was obtained in Example 10.
  • the compression rate was 20%, the recovery rate was 42%, and the fiber diameter was 1.5 m.
  • the cotton-like fiber scaffold 11 is prepared by the following steps:
  • Example 2 The only difference from Example 2 is that the number average molecular weight of polylactic acid in step (1) is 1,000,000, and the content of polylactic acid in the obtained spinning dope is 8 wt%.
  • the cotton-like fiber scaffold 11 was obtained in Example 11.
  • the compression rate was 48%, the recovery rate was 72%, and the fiber diameter was 48 ⁇ m.
  • the cotton-like fiber scaffold 12 is prepared by the following steps:
  • Example 2 The only difference from Example 2 is that the number average molecular weight of polylactic acid in step (1) is 100,000, and the content of polylactic acid in the obtained spinning dope is 14 wt%.
  • Example 12 a cotton-like fiber scaffold 12 was obtained.
  • the compression rate was 42% and the recovery rate was 68% after testing, and the fiber diameter was 36 ⁇ m.
  • the cotton-like fiber scaffolds 1 to 4 obtained in the foregoing Examples 1 to 4 were tested as follows to characterize their biological activity and degradation performance.
  • Figures 1 to 5 are the actual photos of the cotton-like fiber scaffolds 1 to 5 obtained in Examples 1 to 5 of this application. It can be seen from them that the appearance of the cotton-like fiber scaffolds obtained in Examples 2 and 3 of this application is better than other cottons.
  • the cotton-like fiber scaffolds are more fluffy, and the cotton-like fiber scaffolds 1 to 4 obtained by mixing bioglass and polylactic acid are more bulky than the cotton-like fiber scaffold 5 obtained by mixing ⁇ -tricalcium phosphate and polylactic acid.
  • Fig. 6 is an SEM photograph of the cotton-like fiber scaffold 2 obtained in Example 2 of the application after the biological activity test
  • Fig. 7 is the cotton-like fiber scaffold 1 to 3 obtained in Examples 1 to 3 of the application after the biological activity test
  • Fig. 8 is a curve of the weight loss of the cotton-like fiber scaffolds 1 to 4 obtained in Examples 1 to 4 of the application over time in the degradation performance experiment. It can be seen from this that when the content of bioactive materials in the cotton-like fiber scaffold is When there is more, the obtained cotton-like fiber scaffold has stronger degradability.
  • this application uses the method of electrospinning to prepare a composite material of bio-glass, ⁇ -tricalcium phosphate or calcium sulfate and other bioactive materials and polyemulsion, which can obtain a compression rate of up to 45% and recovery
  • the cotton-like fiber scaffold prepared in this application has smaller fiber diameter, stronger flexibility and higher porosity And specific surface area, it can provide more attachment points for osteoblasts, shorten the recovery time, and is suitable for the comprehensive repair of various shapes of bone defects inside and on the surface.
  • the cotton-like fiber scaffold prepared in this application also has excellent biological properties.
  • the inorganic part of it can be degraded in the body to produce calcium, phosphorus and other basic nutrients required for bone formation, and promote bone repair at the defect.
  • the organic part of polylactic acid has a good Degradability and biocompatibility.
  • the final degradation products are carbon dioxide and water, which have no toxic side effects to the human body and are environmentally friendly.

Abstract

A cotton-like fiber scaffold as well as a preparation method therefor and an application thereof. A cotton-like fiber scaffold having a compression ratio as high as 45%, recovery rate as high as 80% and quite high adaptability may be prepared by using an electrostatic spinning method to blend and spin polylactic acid and bioactive materials such as bioglass, beta-tricalcium phosphate or calcium sulfate. The prepared cotton-like fiber scaffold has smaller fiber diameter, higher flexibility and higher porosity and specific surface area, and may provide more attachment points for osteoblasts and shorten rehabilitation time. The scaffold further has excellent biological activity, biocompatibility and biodegradability. An inorganic part in the scaffold may be degraded in vivo to generate elements essential for osteogenesis, and an inorganic part polylactic acid therein has good biodegradability and biocompatibility and may be degraded to generate lactic acid, and then the lactic acid is converted into carbon dioxide and water under the action of enzyme. The cotton-like fiber scaffold has no toxic side effects on a human body.

Description

一种棉花状纤维支架及其制备方法和用途Cotton-like fiber support and preparation method and application thereof 技术领域Technical field
本申请属于生物医用复合材料领域,尤其涉及一种棉花状纤维支架及其制备方法和用途。This application belongs to the field of biomedical composite materials, and in particular relates to a cotton-like fiber scaffold and its preparation method and application.
背景技术Background technique
在日常活动中,因外伤、感染、肿瘤及先天性疾病等原因造成的骨缺损非常常见,骨缺损的治疗和修复是骨科临床常见的难症之一,现有的骨修复材料主要有自体骨、异体骨和人工骨替代品,自体骨存在取用不便,来源有限的问题,异体骨存在组织不兼容性,排斥反应的问题,人工骨替代品在可塑性、组织相容性,生物降解性方面有较高要求,上述条件的限制使得现有技术中得到的人工骨替代品难以满足临床应用的需要。In daily activities, bone defects caused by trauma, infection, tumors and congenital diseases are very common. The treatment and repair of bone defects is one of the common clinical difficulties in orthopedics. The existing bone repair materials mainly include autogenous bone , Allogeneic bone and artificial bone substitutes. Autologous bone has the problem of inconvenience and limited sources. Allogeneic bone has tissue incompatibility and rejection. Artificial bone substitutes are plastic, histocompatibility, and biodegradability. There are high requirements, and the limitations of the above conditions make it difficult for the artificial bone substitutes obtained in the prior art to meet the needs of clinical applications.
静电纺丝法是一种常用的制备纤维丝的方法,静电纺丝法得到的纤维尺寸属于纳米级或亚微米级,具有比表面积大、孔隙率高、空间连通性好等优点,因此常被应用于生物组织工程领域。在骨修复方面,静电纺丝纤维具有相当的优势,其优良的柔韧性,能够适合各种形状的骨缺损,充分填充缺损部位,超高的比表面积和孔隙率有利于成骨细胞能够大量迁移至骨缺损中心部位内部,实现全面快速的修复,除此以外,其超高的孔隙率和良好的连通性,不仅有利于成骨细胞的迁移,还能够促进血管的形成,和营养物质的输送。Electrospinning is a commonly used method for preparing fiber filaments. The size of the fibers obtained by electrospinning is of nanometer or submicron level. It has the advantages of large specific surface area, high porosity, and good spatial connectivity, so it is often used Used in the field of biological tissue engineering. In bone repair, electrospun fiber has considerable advantages. Its excellent flexibility can be suitable for bone defects of various shapes and fully fill the defect. The ultra-high specific surface area and porosity are conducive to the migration of osteoblasts in large numbers. In addition, its ultra-high porosity and good connectivity can not only facilitate the migration of osteoblasts, but also promote the formation of blood vessels and the transportation of nutrients. .
在骨修复领域,生物活性材料也是一个研究热点,尤其是生物玻璃和β-磷酸三钙(β-TCP)等材料,由于其具有良好的生物相容性、生物活性和骨传导性,能够矿化产生与骨组织成分极其相似的羟基磷灰石,且具有优秀的生物降解性, 在体内降解产生的Ca、P等元素,能够参与并促进了体内新骨的形成,属于一种比较成熟的成骨材料。In the field of bone repair, bioactive materials are also a research hotspot, especially materials such as bioglass and β-tricalcium phosphate (β-TCP). Due to their good biocompatibility, bioactivity and osteoconductivity, they can be It produces hydroxyapatite which is very similar to the composition of bone tissue and has excellent biodegradability. The elements such as Ca and P produced by degradation in the body can participate in and promote the formation of new bone in the body. It is a relatively mature Osteogenic material.
聚乳酸(PLLA)材料具有良好的生物相容性、生物降解性和机械性能,具有易于加工等优点,也是骨组织修复领域的热点材料,但其缺点是生物活性较差,缺少成骨能力,因此,利用静电纺丝技术将生物活性陶瓷颗粒和聚乳酸合成制备的复合材料,理论上能够得到机械性能和生物性能均较优的活性骨修复材料。例如,CN106983910A中公开了一种聚乳酸复合生物玻璃组织修复材料的制备方法,其通过将聚乳酸颗粒溶解于氯仿中,得到聚乳酸溶液,之后,将聚环氧乙烷-聚环氧丙烷-聚环氧乙烷三嵌段聚合物溶于乙醇中,向其中加入硅酸乙酯、磷酸三乙酯、硝酸钙和盐酸等组分,得到混合液,将混合液静置粘稠后,与聚乳酸溶液混合,进行静电纺丝,得到所述聚乳酸复合生物玻璃组织修复材料。上述现有技术中的方法,得到的材料多为膜状材料,而且,使用溶胶凝胶法制备生物玻璃再纺丝的过程中并未经过热处理步骤,可能会导致产品中存在大量有机杂质,对人体产生毒害作用,得到的骨植入材料为固定形状,在手术前需要后期加工,操作比较繁琐,在植入后,由于在接缝处会存在一定间隙,使得植入材料与宿主骨无法接触,进而降低骨修复速度。Polylactic acid (PLLA) material has good biocompatibility, biodegradability and mechanical properties, and has the advantages of easy processing. It is also a hot material in the field of bone tissue repair, but its disadvantages are poor biological activity and lack of osteogenic ability. Therefore, using electrospinning technology to synthesize bioactive ceramic particles and polylactic acid to prepare a composite material, theoretically, an active bone repair material with excellent mechanical and biological properties can be obtained. For example, CN106983910A discloses a method for preparing a polylactic acid composite bioglass tissue repair material, which dissolves polylactic acid particles in chloroform to obtain a polylactic acid solution, and then combines polyethylene oxide-polypropylene oxide- Polyethylene oxide triblock polymer is dissolved in ethanol, and ethyl silicate, triethyl phosphate, calcium nitrate, hydrochloric acid and other components are added to it to obtain a mixed liquid. The polylactic acid solution is mixed and electrospinning is performed to obtain the polylactic acid composite bioglass tissue repair material. In the above-mentioned prior art methods, most of the materials obtained are film-like materials. Moreover, the process of preparing bioglass by sol-gel method and re-spinning does not undergo a heat treatment step, which may cause a large amount of organic impurities in the product. The human body has a toxic effect, and the obtained bone implant material is of a fixed shape. It requires post-processing before the operation and the operation is cumbersome. After implantation, there will be a certain gap at the seam, making the implant material unable to contact the host bone , Thereby reducing the speed of bone repair.
因此,在现有技术的基础上,本领域的技术人员需要研发出一种能够适应各种骨缺损的具有较高生物活性的生物骨材料及其高效、便捷、环境友好的制备方法,使其具有类似棉花的高压缩性和高回复性,以完美适应各种骨缺损形状,实现受损骨或牙等硬组织的修复。Therefore, on the basis of the existing technology, those skilled in the art need to develop a biological bone material with high biological activity that can adapt to various bone defects and an efficient, convenient, and environmentally friendly preparation method to make it It has high compressibility and high resilience similar to cotton to perfectly adapt to various bone defect shapes and realize the repair of damaged bones or teeth and other hard tissues.
发明内容Summary of the invention
针对现有技术中存在的不足,本申请的目的在于提供一种能够适应各种骨缺损的具有较高生物活性的生物骨材料及其高效、便捷、环境友好的制备方法, 使其具有类似棉花的高压缩性和高回复性,以完美适应各种骨缺损形状,实现受损骨或牙等硬组织的修复。In view of the deficiencies in the prior art, the purpose of this application is to provide a biological bone material with high biological activity that can adapt to various bone defects and an efficient, convenient, and environmentally friendly preparation method, so that it has a similar cotton The high compressibility and high resilience of the product can perfectly adapt to various bone defect shapes and realize the repair of damaged bones or teeth and other hard tissues.
为达此目的,本申请的目的之一在于提供一种棉花状纤维支架,所述棉花状纤维支架包括将生物活性材料与聚乳酸共混后纺丝得到的复合纤维,复合纤维之间相互缠绕使得得到的纤维支架具有如棉花一般的可压缩性和较高的压缩回复率。To achieve this objective, one of the objectives of the present application is to provide a cotton-like fiber scaffold, the cotton-like fiber scaffold comprising a composite fiber obtained by blending a bioactive material with polylactic acid and spinning the composite fiber. The obtained fiber scaffold has the compressibility and higher compression recovery rate like cotton.
所述生物活性材料包括生物玻璃、β-磷酸三钙和硫酸钙中的任意一种材料或至少两种材料的混合物。The bioactive material includes any one of bioglass, β-tricalcium phosphate and calcium sulfate or a mixture of at least two materials.
本申请利用上述生物活性材料得到的棉花状纤维支架结合了生物活性材料的生物相容性、可降解性以聚乳酸材料优良的机械性能,其棉花状的外观以及足够的可压缩性使其在植入体内后能够完美适应各种骨缺损形状,在降解过程中产生成骨元素,促进成骨因子的生成,以实现受损骨或牙等硬组织的修复。The cotton-like fiber scaffold obtained by using the above-mentioned biologically active material in this application combines the biocompatibility and degradability of the biologically active material with the excellent mechanical properties of polylactic acid material, its cotton-like appearance and sufficient compressibility to make it in After being implanted in the body, it can perfectly adapt to various bone defect shapes, produce osteogenic elements during the degradation process, promote the generation of osteogenic factors, and achieve the repair of damaged bones or teeth and other hard tissues.
优选地,所述复合纤维中,生物活性材料与聚乳酸的重量比为0.4~1.5:1,例如为0.45:1、0.50:1、0.55:1、0.60:1、0.65:1、0.70:1、0.75:1、0.80:1、0.85:1、0.90:1、0.95:1、1.00:1、1.05:1、1.10:1、1.15:1、1.20:1、1.25:1、1.30:1、1.35:1、1.4:1或1.45:1等,在上述配比下,得到的复合纤维具有较优的力学性能、可压缩性能、回复性能、生物活性、降解性能以及生物相容性,进一步优选为0.65~1:1。Preferably, in the composite fiber, the weight ratio of the bioactive material to the polylactic acid is 0.4 to 1.5:1, for example, 0.45:1, 0.50:1, 0.55:1, 0.60:1, 0.65:1, 0.70:1 , 0.75:1, 0.80:1, 0.85:1, 0.90:1, 0.95:1, 1.00:1, 1.05:1, 1.10:1, 1.15:1, 1.20:1, 1.25:1, 1.30:1, 1.35 : 1, 1.4:1 or 1.45:1, etc. Under the above ratio, the obtained composite fiber has better mechanical properties, compressibility, recovery performance, biological activity, degradation performance and biocompatibility, and is more preferably 0.65~1:1.
优选地,所述生物活性材料为生物玻璃。Preferably, the bioactive material is bioglass.
优选地,所述生物玻璃为含有二氧化硅、氧化钙、五氧化二磷和添加物的生物玻璃,所述添加物为氧化钠、氧化钾、氧化镁、氧化铝和氟化钙中的任意一种或至少两种的混合物。Preferably, the bioglass is a bioglass containing silica, calcium oxide, phosphorus pentoxide and additives, and the additives are any of sodium oxide, potassium oxide, magnesium oxide, aluminum oxide, and calcium fluoride. One or a mixture of at least two.
优选地,所述生物玻璃为45S5型、AW型、Bioverit型、Ceravital型和58S型生物玻璃中的任意一种或至少两种的混合物。Preferably, the bioglass is any one or a mixture of at least two of 45S5 type, AW type, Bioverit type, Ceravital type and 58S type bioglass.
优选地,所述生物玻璃经过球磨处理,粒径为0.5~30μm,例如为0.6μm、0.8μm、1.2μm、2μm、4μm、6μm、8μm、10μm、12μm、14μm、16μm、18μm、20μm、22μm、24μm、26μm、28μm或29μm等,上述粒径范围的生物玻璃具有较优的纺丝成纤能力,生物玻璃的粒径过高难以成纤,粒径过低则容易导致生物玻璃在纺丝得到的复合纤维中分布不均匀,降低复合纤维的力学性能和降解性能。Preferably, the biological glass is ball-milled and has a particle size of 0.5-30 μm, such as 0.6 μm, 0.8 μm, 1.2 μm, 2 μm, 4 μm, 6 μm, 8 μm, 10 μm, 12 μm, 14 μm, 16 μm, 18 μm, 20 μm, 22 μm. , 24μm, 26μm, 28μm or 29μm, etc., the bioglass in the above particle size range has excellent spinning and fiberizing ability. If the particle size of the bioglass is too high, it is difficult to fiberize, and the particle size is too low, which will easily cause the bioglass to spin The obtained composite fiber is unevenly distributed, which reduces the mechanical properties and degradation performance of the composite fiber.
本领域的技术人员能够根据需求通过适当调整聚乳酸的分子量或静电纺丝的工艺参数获得任意一种直径的复合纤维,优选地,所述复合纤维的直径为1~50μm,例如为2μm、4μm、6μm、10μm、15μm、20μm、25μm、30μm、35μm、40μm、45μm或48μm等。Those skilled in the art can obtain composite fibers of any diameter by appropriately adjusting the molecular weight of polylactic acid or the process parameters of electrospinning according to requirements. Preferably, the diameter of the composite fibers is 1-50 μm, for example, 2 μm, 4 μm. , 6μm, 10μm, 15μm, 20μm, 25μm, 30μm, 35μm, 40μm, 45μm or 48μm etc.
优选地,所述聚乳酸的数均分子量为100000~1000000,例如为105000、125000、150000、200000、250000、300000、350000、400000、450000、500000、550000、600000、650000、700000、750000、800000、850000、900000、950000或980000等。Preferably, the number average molecular weight of the polylactic acid is 100,000 to 1,000,000, such as 105,000, 125,000, 150,000, 200,000, 250,000, 300,000, 350,000, 400000, 450,000, 500,000, 550,000, 600000, 650,000, 700000, 750,000, 800000, 850,000, 900,000, 950,000 or 980000, etc.
本申请的目的之二在于提供一种所述棉花状纤维支架的制备方法,所述制备方法包括如下步骤:The second objective of the present application is to provide a method for preparing the cotton-like fiber scaffold, which includes the following steps:
步骤(1):将生物活性材料与聚乳酸混合,混合物用有机溶剂溶解,得到纺丝原液;Step (1): mixing the bioactive material with polylactic acid, and dissolving the mixture with an organic solvent to obtain a spinning dope;
步骤(2):使用静电纺丝设备对步骤(1)中得到的纺丝原液进行静电纺丝,静电纺丝产物用醇类收集;以及Step (2): Electrospin the spinning dope obtained in step (1) using an electrostatic spinning device, and collect the electrostatic spinning product with alcohol; and
步骤(3):取出步骤(2)的醇类中的凝固后的复合纤维丝,将其干燥后即得到所述棉花状纤维支架。Step (3): Take out the coagulated composite fiber filaments in the alcohol of step (2), and dry them to obtain the cotton-like fiber scaffold.
优选地,步骤(1)中所述的有机溶剂为氯仿。Preferably, the organic solvent described in step (1) is chloroform.
优选地,按重量百分数计算,步骤(1)中所述的纺丝原液中聚乳酸的含量为8~14wt%,例如为8.5wt%、9wt%、9.5wt%、10wt%、10.5wt%、11wt%、11.5wt%、12wt%、12.5wt%、13wt%、13.5wt%或13.8wt%等。Preferably, calculated as a percentage by weight, the content of polylactic acid in the spinning dope described in step (1) is 8-14% by weight, such as 8.5% by weight, 9% by weight, 9.5% by weight, 10% by weight, 10.5% by weight, 11wt%, 11.5wt%, 12wt%, 12.5%, 13wt%, 13.5wt% or 13.8wt%, etc.
优选地,步骤(2)中所述静电纺丝过程中,静电纺丝设备中纺丝原液的挤出速度为0.05~0.4mL/min,例如为0.08mL/min、0.1mL/min、0.13mL/min、0.15mL/min、0.18mL/min、0.20mL/min、0.25mL/min、0.30mL/min、0.35mL/min或0.38mL/min等。Preferably, in the electrospinning process in step (2), the extrusion speed of the spinning dope in the electrospinning equipment is 0.05 to 0.4 mL/min, for example, 0.08 mL/min, 0.1 mL/min, 0.13 mL /min, 0.15mL/min, 0.18mL/min, 0.20mL/min, 0.25mL/min, 0.30mL/min, 0.35mL/min or 0.38mL/min, etc.
优选地,步骤(2)中所述静电纺丝的电压为10~30kV,例如为12kV、14kV、16kV、18kV、20kV、22kV、24kV、26kV或28kV等。Preferably, the voltage of the electrospinning in step (2) is 10-30kV, such as 12kV, 14kV, 16kV, 18kV, 20kV, 22kV, 24kV, 26kV or 28kV.
优选地,步骤(2)中所述的静电纺丝设备中,纺丝喷嘴与纺丝接收设备之间的距离为5~30cm,例如为6cm、8cm、10cm、12cm、14cm、16cm、18cm、20cm、22cm、24cm、26cm或28cm等。Preferably, in the electrostatic spinning device described in step (2), the distance between the spinning nozzle and the spinning receiving device is 5-30 cm, for example, 6 cm, 8 cm, 10 cm, 12 cm, 14 cm, 16 cm, 18 cm, 20cm, 22cm, 24cm, 26cm or 28cm, etc.
优选地,步骤(2)中所述的醇类为乙醇。Preferably, the alcohol mentioned in step (2) is ethanol.
优选地,步骤(3)中所述的干燥在通风橱中进行。Preferably, the drying described in step (3) is performed in a fume hood.
优选地,步骤(3)中所述干燥的温度为室温,干燥的时间为24~48h,例如为25h、27h、29h、31h、33h、35h、37h、39h、41h、43h、45h或47h等。Preferably, the drying temperature in step (3) is room temperature, and the drying time is 24-48h, such as 25h, 27h, 29h, 31h, 33h, 35h, 37h, 39h, 41h, 43h, 45h or 47h, etc. .
优选地,所述制备方法包括如下步骤:Preferably, the preparation method includes the following steps:
步骤(1):将生物玻璃与乙醇混合,混合物经过球磨处理,经干燥、筛分得到粒径为0.5~30μm的预处理后的生物玻璃,之后将预处理后的生物玻璃与聚乳酸按重量比0.4~1.5:1混合,混合物用氯仿溶解,得到聚乳酸含量为8~14wt%的纺丝原液;Step (1): The bioglass is mixed with ethanol, the mixture is ball milled, dried and sieved to obtain a pretreated bioglass with a particle size of 0.5-30μm, and then the pretreated bioglass and polylactic acid are weighted Mix at a ratio of 0.4 to 1.5:1, and dissolve the mixture with chloroform to obtain a spinning dope with a polylactic acid content of 8 to 14 wt%;
步骤(2):将步骤(1)中得到的纺丝原液注入静电纺丝设备的注射器中, 控制静电纺丝设备的电压为10~30kV,注射器以0.05~0.4mL/min的挤出速度挤出纺丝原液,纺丝喷嘴与纺丝接收设备之间的距离为5~30cm,纺丝接收设备中填充有无水乙醇,用于收集静电纺丝的产物;以及Step (2): Inject the spinning stock solution obtained in step (1) into the syringe of the electrospinning equipment, control the voltage of the electrospinning equipment to 10-30kV, and extrude the syringe at an extrusion speed of 0.05-0.4mL/min The spinning dope is output, the distance between the spinning nozzle and the spinning receiving device is 5-30cm, and the spinning receiving device is filled with absolute ethanol to collect the product of electrospinning; and
步骤(3):取出步骤(2)中收集到的凝固在纺丝接收设备中的无水乙醇中的复合纤维丝,将其转移至通风橱中,在室温下干燥24~48h,干燥后即得到所述棉花状纤维支架。Step (3): Take out the composite fiber filaments coagulated in absolute ethanol in the spinning receiving equipment collected in step (2), transfer them to a fume hood, and dry them at room temperature for 24 to 48 hours. The cotton-like fiber scaffold is obtained.
本申请的目的之三在于提供一种所述棉花状纤维支架在骨修复或牙齿硬组织修复领域中的应用。The third purpose of the present application is to provide an application of the cotton-like fiber scaffold in the field of bone repair or tooth hard tissue repair.
本申请所述的数值范围不仅包括上述例举的点值,还包括没有例举出的上述数值范围之间的任意的点值,限于篇幅及出于简明的考虑,本申请不再穷尽列举所述范围包括的具体点值。The numerical range described in this application not only includes the above-exemplified point values, but also includes any point value between the above-mentioned numerical ranges that are not exemplified. Due to the limitation of space and for the sake of brevity, this application will not exhaustively list all the points. The specific point value included in the stated range.
与现有技术相比,本申请的有益效果为:Compared with the prior art, the beneficial effects of this application are:
(1)本申请利用静电纺丝的方法,能够获得一种压缩率可达45%、回复率可达80%的具有极高适应性的棉花状纤维支架,相较于传统的拉丝方法,本申请制备的棉花状纤维支架中的纤维直径更小、柔性更强且具有较高的孔隙率和比表面积,能够为成骨细胞提供更多的附着点,减短康复时间,适用于各种形状的骨缺损在内部和表面的全面修复。(1) This application uses the method of electrospinning to obtain a highly adaptable cotton-like fiber scaffold with a compression rate of up to 45% and a recovery rate of up to 80%. Compared with the traditional drawing method, this The cotton-like fiber scaffold prepared by the application has a smaller fiber diameter, stronger flexibility, and higher porosity and specific surface area, which can provide more attachment points for osteoblasts, shorten the recovery time, and is suitable for various shapes The bone defect is completely repaired internally and on the surface.
(2)本申请制备的棉花状纤维支架还具有优良的生物活性、生物相容性和生物可降解性,其中的无机部分可以在体内降解产生钙、磷等成骨所需要的基本营养元素,促进缺损处的骨修复,其中的有机部分聚乳酸具有良好的可降解性和生物相容性,会在体内降解成为乳酸,然后在酶的作用下转化为二氧化碳和水,排出体外,对人体无毒性副作用。(2) The cotton-like fiber scaffold prepared in this application also has excellent biological activity, biocompatibility and biodegradability. The inorganic part of it can be degraded in the body to produce calcium, phosphorus and other basic nutrients required for bone formation. Promote bone repair in the defect. The organic part of polylactic acid has good degradability and biocompatibility. It will be degraded into lactic acid in the body, and then converted into carbon dioxide and water under the action of enzymes. Toxic side effects.
附图说明Description of the drawings
图1为本申请具体实施方式中实施例1得到的棉花状纤维支架1的实物照片。Figure 1 is a physical photo of the cotton-like fiber scaffold 1 obtained in Example 1 in the specific implementation of the application.
图2为本申请具体实施方式中实施例2得到的棉花状纤维支架2的实物照片。Figure 2 is a physical photo of the cotton-like fiber scaffold 2 obtained in Example 2 of the specific implementation of the application.
图3为本申请具体实施方式中实施例3得到的棉花状纤维支架3的实物照片。Figure 3 is a physical photo of the cotton-like fiber scaffold 3 obtained in Example 3 in the specific implementation of the application.
图4为本申请具体实施方式中实施例4得到的棉花状纤维支架4的实物照片。FIG. 4 is a physical photo of the cotton-like fiber scaffold 4 obtained in Example 4 in the specific embodiment of the application.
图5为本申请具体实施方式中实施例5得到的棉花状纤维支架5的实物照片。FIG. 5 is a physical photo of the cotton-like fiber scaffold 5 obtained in Example 5 in the specific embodiment of the application.
图6为本申请具体实施方式中实施例2得到的棉花状纤维支架2在经过生物活性试验后的SEM照片。Fig. 6 is an SEM photograph of the cotton-like fiber scaffold 2 obtained in Example 2 in the specific embodiment of the application after the biological activity test.
图7为本申请具体实施方式中实施例1~3得到的棉花状纤维支架1~3在经过生物活性试验后的XRD谱。Fig. 7 shows the XRD spectra of the cotton-like fiber scaffolds 1 to 3 obtained in Examples 1 to 3 in the specific embodiment of the application after the biological activity test.
图8为本申请具体实施方式中实施例1~4得到的棉花状纤维支架1~4在降解性能实验中各自的失重情况随时间的变化曲线。Fig. 8 is a curve of the weight loss of the cotton-like fiber scaffolds 1 to 4 obtained in Examples 1 to 4 in the specific embodiments of the application in the degradation performance experiment over time.
具体实施方式detailed description
下面通过具体实施方式来进一步说明本申请的技术方案。The technical solution of the present application will be further explained through specific implementations below.
本申请中选用的生物玻璃为市售的45S5型、AW型、Bioverit型、Ceravital型和58S型生物玻璃中的任意一种或至少两种生物玻璃的混合物,各型生物玻璃的详细组分如表1中所示。The bioglass selected in this application is any one of 45S5, AW, Bioverit, Ceravital and 58S bioglasses or a mixture of at least two bioglasses. The detailed components of each type of bioglass are as follows: Shown in Table 1.
表1各型生物玻璃的详细组分及含量对照表Table 1 Detailed composition and content comparison table of various types of bioglass
Figure PCTCN2019110974-appb-000001
Figure PCTCN2019110974-appb-000001
其中“/”表示不含该组分。Wherein "/" means that the component is not included.
本申请对于各实施例和对照例中得到的棉花状纤维支架的性能测试方法如下:The performance test methods of the cotton-like fiber scaffolds obtained in each embodiment and comparative example in this application are as follows:
压缩率和回复率测试:取制得的棉花状纤维支架0.05g,将其置于内径为22mm的玻璃管中,将具有同样直径的圆形玻璃盖(重1g)平置于玻璃管中的棉花状纤维支架之上,测量圆形玻璃盖底至玻璃管底的高度,记为h 0,之后,在玻璃盖上放置10g砝码,静置30min后,测试玻璃盖底至玻璃管底的高度,记为h 1,最后,将砝码轻轻移除,静置30min后,再次测试玻璃盖底至玻璃管底高度,记为h 2,得到待测棉花状纤维支架的压缩率=[(h 0-h 1)×100%]/h 0,回复率=[(h 2-h 1)×100%]/(h 0-h 1)。 Compression rate and recovery rate test: Take 0.05g of the prepared cotton-like fiber scaffold and place it in a glass tube with an inner diameter of 22mm. Place a round glass cover (weight 1g) with the same diameter in the glass tube. On the cotton-like fiber support, measure the height from the bottom of the round glass cover to the bottom of the glass tube and record it as h 0. Then, place a 10g weight on the glass cover and let it stand for 30 minutes. The height is recorded as h 1 , finally, the weight is gently removed, and after standing for 30 minutes, the height from the bottom of the glass cover to the bottom of the glass tube is tested again, recorded as h 2 , to obtain the compression rate of the cotton-like fiber support to be tested =[ (h 0 -h 1 )×100%]/h 0 , the response rate=[(h 2 -h 1 )×100%]/(h 0 -h 1 ).
纤维直径测试:利用日本理学株式会社生产的JSM-2100F型扫描电子显微镜(SEM)测试制得的棉花状纤维支架的微观形貌,并计算其中纤维的平均直径,记为所述棉花状纤维支架中纤维的直径。Fiber diameter test: Use the JSM-2100F scanning electron microscope (SEM) produced by Rigaku Corporation to test the microscopic morphology of the cotton-like fiber scaffold, and calculate the average fiber diameter, and record it as the cotton-like fiber scaffold The diameter of the fiber.
实施例1Example 1
通过如下步骤制备棉花状纤维支架1:Prepare cotton-like fiber scaffold 1 through the following steps:
步骤(1):取30g 45S5型生物玻璃与10mL研磨液乙醇混合,混合物经过球磨处理,得到粒径为15μm的预处理后的生物玻璃,之后将预处理后的生物玻璃与70g数均分子量为350000的聚乳酸混合,混合物用氯仿溶解,得到聚乳酸含量为12wt%的纺丝原液;Step (1): Take 30g of 45S5 type bioglass and mix with 10mL of grinding liquid ethanol. The mixture is subjected to ball milling treatment to obtain a pretreated bioglass with a particle size of 15μm. Then, the pretreated bioglass and 70g number average molecular weight 350,000 polylactic acid is mixed, and the mixture is dissolved in chloroform to obtain a spinning dope with a polylactic acid content of 12 wt%;
步骤(2):将步骤(1)中得到的纺丝原液注入静电纺丝设备的注射器中,控制静电纺丝设备的电压为20kV,注射器以0.2mL/min的挤出速度挤出纺丝原液,纺丝喷嘴与纺丝接收设备之间的距离为20cm,纺丝接收设备中填充有无水乙醇,用于收集静电纺丝的产物;Step (2): Inject the spinning dope obtained in step (1) into the syringe of the electrostatic spinning equipment, control the voltage of the electrostatic spinning equipment to 20kV, and the syringe extrudes the spinning dope at an extrusion speed of 0.2mL/min , The distance between the spinning nozzle and the spinning receiving device is 20cm, and the spinning receiving device is filled with anhydrous ethanol to collect the products of electrospinning;
步骤(3):取出步骤(2)中收集到的凝固在纺丝接收设备中的无水乙醇中的复合纤维丝,得到湿润的棉花状纤维团,将其转移至通风橱中,在室温下干燥24~48h,干燥后即得到所述棉花状纤维支架1(BG/PLLA=3/7)。Step (3): Take out the composite fiber filaments coagulated in absolute ethanol in the spinning receiving equipment collected in step (2) to obtain a wet cotton-like fiber mass, which is transferred to a fume hood, and at room temperature After drying for 24 to 48 hours, the cotton-like fiber scaffold 1 (BG/PLLA=3/7) is obtained after drying.
实施例1中得到的棉花状纤维支架1,经过测试得到其压缩率为35%,回复率为35%,其中纤维的直径为35μm。The cotton-like fiber scaffold 1 obtained in Example 1 has a compression rate of 35% and a recovery rate of 35% after testing, and the fiber diameter is 35 μm.
实施例2Example 2
通过如下步骤制备棉花状纤维支架2:Prepare cotton-like fiber scaffold 2 through the following steps:
与实施例1的区别仅在于,步骤(1)中生物玻璃的加入量为40g,聚乳酸的加入量为60g,且纺丝原液中聚乳酸的含量仍为12wt%。The only difference from Example 1 is that the amount of bioglass added in step (1) is 40g, the amount of polylactic acid added is 60g, and the content of polylactic acid in the spinning dope is still 12wt%.
实施例2得到棉花状纤维支架2(BG/PLLA=4/6),经过测试得到其压缩率为45%,回复率为75%,其中纤维的直径为38μm。In Example 2, a cotton-like fiber scaffold 2 (BG/PLLA=4/6) was obtained. After testing, the compression rate was 45%, the recovery rate was 75%, and the fiber diameter was 38 μm.
实施例3Example 3
通过如下步骤制备棉花状纤维支架3:Prepare cotton-like fiber scaffold 3 through the following steps:
与实施例1的区别仅在于,步骤(1)中生物玻璃的加入量为50g,聚乳酸 的加入量为50g,且纺丝原液中聚乳酸的含量仍为12wt%。The only difference from Example 1 is that the amount of bioglass added in step (1) is 50g, the amount of polylactic acid added is 50g, and the content of polylactic acid in the spinning dope is still 12wt%.
实施例3得到棉花状纤维支架3(BG/PLLA=5/5),经过测试得到其压缩率为40%,回复率为80%,其中纤维的直径为40μm。In Example 3, a cotton-like fiber scaffold 3 (BG/PLLA=5/5) was obtained. The compression rate was 40%, the recovery rate was 80%, and the fiber diameter was 40 μm.
实施例4Example 4
通过如下步骤制备棉花状纤维支架4:Prepare cotton-like fiber scaffold 4 through the following steps:
与实施例1的区别仅在于,步骤(1)中生物玻璃的加入量为60g,聚乳酸的加入量为40g,且纺丝原液中聚乳酸的含量仍为12wt%。The only difference from Example 1 is that the amount of bioglass added in step (1) is 60g, the amount of polylactic acid added is 40g, and the content of polylactic acid in the spinning dope is still 12wt%.
实施例4得到棉花状纤维支架4(BG/PLLA=6/4),经过测试得到其压缩率为20%,回复率为60%,其中纤维的直径为44μm。In Example 4, a cotton-like fiber scaffold 4 (BG/PLLA=6/4) was obtained. The compression rate was 20%, the recovery rate was 60%, and the fiber diameter was 44 μm.
实施例5Example 5
通过如下步骤制备棉花状纤维支架5:Prepare cotton-like fiber scaffold 5 through the following steps:
与实施例2的区别仅在于,步骤(1)中的生物玻璃替换为β-磷酸三钙。The only difference from Example 2 is that the bioglass in step (1) is replaced with β-tricalcium phosphate.
实施例5得到棉花状纤维支架5,经过测试得到其压缩率为40%,回复率为40%,其中纤维的直径为42μm。In Example 5, a cotton-like fiber scaffold 5 was obtained. After testing, the compression rate was 40% and the recovery rate was 40%, and the fiber diameter was 42 μm.
实施例6Example 6
通过如下步骤制备棉花状纤维支架6:Prepare cotton-like fiber scaffold 6 through the following steps:
与实施例2的区别仅在于,步骤(1)中的生物玻璃替换为硫酸钙。The only difference from Example 2 is that the bioglass in step (1) is replaced with calcium sulfate.
实施例6得到棉花状纤维支架6,经过测试得到其压缩率为40%,回复率为45%,其中纤维的直径为38μm。In Example 6, a cotton-like fiber scaffold 6 was obtained. The compression rate was 40% and the recovery rate was 45% after testing, and the fiber diameter was 38 μm.
实施例7Example 7
通过如下步骤制备棉花状纤维支架7:Prepare cotton-like fiber scaffold 7 through the following steps:
与实施例2的区别仅在于,步骤(1)中的生物玻璃替换为AW型、Bioverit型和Ceravital型生物玻璃按重量比1:1:1混合得到的混合物。The only difference from Example 2 is that the bioglass in step (1) is replaced with a mixture of AW, Bioverit, and Ceravital bioglass at a weight ratio of 1:1:1.
实施例7得到棉花状纤维支架7,经过测试得到其压缩率为44%,回复率为72%,其中纤维的直径为40μm。The cotton-like fiber scaffold 7 was obtained in Example 7. The compression rate was 44%, the recovery rate was 72%, and the fiber diameter was 40 μm.
实施例8Example 8
通过如下步骤制备棉花状纤维支架8:Prepare cotton-like fiber scaffold 8 through the following steps:
与实施例2的区别仅在于,步骤(1)中的生物玻璃经过球磨处理,得到粒径为0.5μm的预处理后的生物玻璃,步骤(2)中静电纺丝设备的电压为10kV,注射器以0.4mL/min的挤出速度挤出纺丝原液,纺丝喷嘴与纺丝接收设备之间的距离为30cm,The only difference from Example 2 is that the bioglass in step (1) is ball milled to obtain a pretreated bioglass with a particle size of 0.5μm. The voltage of the electrospinning equipment in step (2) is 10kV, and the syringe Extrude the spinning dope at an extrusion speed of 0.4mL/min, and the distance between the spinning nozzle and the spinning receiving device is 30cm,
实施例8得到棉花状纤维支架8,经过测试得到其压缩率为35%,回复率为71%,其中纤维的直径为2μm。The cotton-like fiber scaffold 8 was obtained in Example 8. The compression rate was 35%, the recovery rate was 71%, and the fiber diameter was 2 μm.
实施例9Example 9
通过如下步骤制备棉花状纤维支架9:The cotton-like fiber scaffold 9 is prepared by the following steps:
与实施例2的区别仅在于,步骤(1)中的生物玻璃经过球磨处理,得到粒径为28μm的预处理后的生物玻璃,步骤(2)中静电纺丝设备的电压为30kV,注射器以0.08mL/min的挤出速度挤出纺丝原液,纺丝喷嘴与纺丝接收设备之间的距离为5cm,。The only difference from Example 2 is that the bioglass in step (1) is ball milled to obtain pretreated bioglass with a particle size of 28μm. In step (2), the voltage of the electrospinning equipment is 30kV, and the syringe is The extrusion speed of 0.08mL/min extrudes the spinning dope, and the distance between the spinning nozzle and the spinning receiving device is 5cm.
实施例9得到棉花状纤维支架9,经过测试得到其压缩率为44%,回复率为55%,其中纤维的直径为50μm。The cotton-like fiber scaffold 9 was obtained in Example 9. The compression rate was 44%, the recovery rate was 55%, and the fiber diameter was 50 μm.
实施例10Example 10
通过如下步骤制备棉花状纤维支架10:The cotton-like fiber scaffold 10 is prepared by the following steps:
与实施例8的区别仅在于,步骤(1)中的生物玻璃经过球磨处理,得到粒径为0.1μm的预处理后的生物玻璃。The only difference from Example 8 is that the bioglass in step (1) is ball milled to obtain a pretreated bioglass with a particle size of 0.1 μm.
实施例10得到棉花状纤维支架10,经过测试得到其压缩率为20%,回复率 为42%,其中纤维的直径为1.5μm。The cotton-like fiber scaffold 10 was obtained in Example 10. The compression rate was 20%, the recovery rate was 42%, and the fiber diameter was 1.5 m.
实施例11Example 11
通过如下步骤制备棉花状纤维支架11:The cotton-like fiber scaffold 11 is prepared by the following steps:
与实施例2的区别仅在于,步骤(1)中聚乳酸的数均分子量为1000000,且得到的纺丝原液中聚乳酸的含量为8wt%。The only difference from Example 2 is that the number average molecular weight of polylactic acid in step (1) is 1,000,000, and the content of polylactic acid in the obtained spinning dope is 8 wt%.
实施例11得到棉花状纤维支架11,经过测试得到其压缩率为48%,回复率为72%,其中纤维的直径为48μm。The cotton-like fiber scaffold 11 was obtained in Example 11. The compression rate was 48%, the recovery rate was 72%, and the fiber diameter was 48 μm.
实施例12Example 12
通过如下步骤制备棉花状纤维支架12:The cotton-like fiber scaffold 12 is prepared by the following steps:
与实施例2的区别仅在于,步骤(1)中聚乳酸的数均分子量为100000,且得到的纺丝原液中聚乳酸的含量为14wt%。The only difference from Example 2 is that the number average molecular weight of polylactic acid in step (1) is 100,000, and the content of polylactic acid in the obtained spinning dope is 14 wt%.
实施例12得到棉花状纤维支架12,经过测试得到其压缩率为42%,回复率为68%,其中纤维的直径为36μm。In Example 12, a cotton-like fiber scaffold 12 was obtained. The compression rate was 42% and the recovery rate was 68% after testing, and the fiber diameter was 36 μm.
对上述实施例1~4中得到的棉花状纤维支架1~4进行如下测试,以表征其生物活性和降解性能。The cotton-like fiber scaffolds 1 to 4 obtained in the foregoing Examples 1 to 4 were tested as follows to characterize their biological activity and degradation performance.
(1)生物活性试验(1) Biological activity test
分别取实施例1~4中得到的棉花状纤维支架1~4各1g,置于100mL模拟体液(SBF溶液)中,以模拟体内环境的作用,浸泡2个月后取出,分别通过SEM和X射线衍射仪(XRD)观察棉花状纤维支架1~4的微观结构和矿化能力。Take 1g each of the cotton-like fiber scaffolds 1 to 4 obtained in Examples 1 to 4 and place them in 100 mL of simulated body fluid (SBF solution) to simulate the effect of the internal environment. After soaking for 2 months, take them out and pass them through SEM and X respectively. XRD was used to observe the microstructure and mineralization ability of cotton-like fiber scaffolds 1-4.
(2)降解性能实验(2) Degradation performance test
分别取实施例1~4中得到的棉花状纤维支架1~4各1g,置于100mL Tris-HCl缓冲溶液中,测试不同时间的失重,以表征棉花状纤维支架1~4的生物降解性能。Take 1g each of the cotton-like fiber scaffolds 1 to 4 obtained in Examples 1 to 4, and place them in 100 mL Tris-HCl buffer solution to test the weight loss at different times to characterize the biodegradability of the cotton-like fiber scaffolds 1 to 4.
图1~5分别为本申请实施例1~5得到的棉花状纤维支架1~5的实物照片,从中可以看出,本申请实施例2和实施例3得到的棉花状纤维支架外观较其他棉花状纤维支架更为蓬松,而且,由生物玻璃和聚乳酸混合得到的棉花状纤维支架1~4外观均较由β-磷酸三钙和聚乳酸混合得到的棉花状纤维支架5蓬松。Figures 1 to 5 are the actual photos of the cotton-like fiber scaffolds 1 to 5 obtained in Examples 1 to 5 of this application. It can be seen from them that the appearance of the cotton-like fiber scaffolds obtained in Examples 2 and 3 of this application is better than other cottons. The cotton-like fiber scaffolds are more fluffy, and the cotton-like fiber scaffolds 1 to 4 obtained by mixing bioglass and polylactic acid are more bulky than the cotton-like fiber scaffold 5 obtained by mixing β-tricalcium phosphate and polylactic acid.
图6为本申请实施例2得到的棉花状纤维支架2在经过生物活性试验后的SEM照片,图7为本申请实施例1~3得到的棉花状纤维支架1~3在经过生物活性试验后的XRD谱,从中可以明显看出,因其自身含有多种矿化所需的Ca、P元素,使得本申请得到的棉花状纤维支架能够在体液环境中自行矿化,矿化后的产物中能够明显看出羟基磷灰石(HA)的生成,而且,当其中的生物活性材料与聚乳酸的重量比为0.65~1:1时,矿化的效果最优。Fig. 6 is an SEM photograph of the cotton-like fiber scaffold 2 obtained in Example 2 of the application after the biological activity test, and Fig. 7 is the cotton-like fiber scaffold 1 to 3 obtained in Examples 1 to 3 of the application after the biological activity test It can be clearly seen from the XRD spectrum that the cotton-like fiber scaffold obtained in this application can self-mineralize in the body fluid environment because it contains a variety of Ca and P elements required for mineralization. The formation of hydroxyapatite (HA) can be clearly seen, and when the weight ratio of the bioactive material to polylactic acid is 0.65 to 1:1, the mineralization effect is optimal.
图8为本申请实施例1~4得到的棉花状纤维支架1~4在降解性能实验中各自的失重情况随时间的变化曲线,从中可以看出,当棉花状纤维支架中生物活性材料的含量越多时,得到的棉花状纤维支架具有更强的降解能力。Fig. 8 is a curve of the weight loss of the cotton-like fiber scaffolds 1 to 4 obtained in Examples 1 to 4 of the application over time in the degradation performance experiment. It can be seen from this that when the content of bioactive materials in the cotton-like fiber scaffold is When there is more, the obtained cotton-like fiber scaffold has stronger degradability.
综上所述,本申请利用静电纺丝的方法,制备了生物玻璃、β-磷酸三钙或硫酸钙等生物活性材料与聚乳的复合材料,能够获得一种压缩率可达45%、回复率可达80%的具有极高适应性的棉花状纤维支架,相较于传统的拉丝方法,本申请制备的棉花状纤维支架中的纤维直径更小、柔性更强且具有较高的孔隙率和比表面积,能够为成骨细胞提供更多的附着点,减短康复时间,适用于各种形状的骨缺损在内部和表面的全面修复,本申请制备的棉花状纤维支架还具有优良的生物活性、生物相容性和生物可降解性,其中的无机部分可以在体内降解产生钙、磷等成骨所需要的基本营养元素,促进缺损处的骨修复,其中的有机部分聚乳酸具有良好的可降解性和生物相容性,最终降解产物为二氧化碳和水,对人体无毒性副作用,还具有环境友好的优点。In summary, this application uses the method of electrospinning to prepare a composite material of bio-glass, β-tricalcium phosphate or calcium sulfate and other bioactive materials and polyemulsion, which can obtain a compression rate of up to 45% and recovery A cotton-like fiber scaffold with extremely high adaptability with a rate of up to 80%. Compared with the traditional drawing method, the cotton-like fiber scaffold prepared in this application has smaller fiber diameter, stronger flexibility and higher porosity And specific surface area, it can provide more attachment points for osteoblasts, shorten the recovery time, and is suitable for the comprehensive repair of various shapes of bone defects inside and on the surface. The cotton-like fiber scaffold prepared in this application also has excellent biological properties. Activity, biocompatibility and biodegradability, the inorganic part of it can be degraded in the body to produce calcium, phosphorus and other basic nutrients required for bone formation, and promote bone repair at the defect. The organic part of polylactic acid has a good Degradability and biocompatibility. The final degradation products are carbon dioxide and water, which have no toxic side effects to the human body and are environmentally friendly.
申请人声明,以上所述仅为本申请的具体实施方式,但本申请的保护范围并不局限于此,所属技术领域的技术人员应该明了,任何属于本技术领域的技术人员在本申请揭露的技术范围内,可轻易想到的变化或替换,均落在本申请的保护范围和公开范围之内。The applicant declares that the above are only specific implementations of this application, but the scope of protection of this application is not limited to this, and those skilled in the art should understand that any person skilled in the art disclosed in this application Any changes or substitutions that can be easily conceived within the technical scope fall within the scope of protection and disclosure of this application.

Claims (15)

  1. 一种棉花状纤维支架,其包括将生物活性材料与聚乳酸共混后纺丝得到的复合纤维;A cotton-like fiber scaffold, which comprises composite fibers obtained by spinning bioactive materials and polylactic acid after blending;
    其中,所述生物活性材料包括生物玻璃、β-磷酸三钙和硫酸钙中的任意一种材料或至少两种材料的混合物。Wherein, the bioactive material includes any one material or a mixture of at least two materials among bioglass, β-tricalcium phosphate and calcium sulfate.
  2. 根据权利要求1所述的棉花状纤维支架,其中,在所述复合纤维中,生物活性材料与聚乳酸的重量比为0.4~1.5:1。The cotton-like fiber scaffold according to claim 1, wherein the weight ratio of the bioactive material to the polylactic acid in the composite fiber is 0.4 to 1.5:1.
  3. 根据权利要求1所述的棉花状纤维支架,其中,在所述复合纤维中,生物活性材料与聚乳酸的重量比为0.65~1:1。The cotton-like fiber scaffold according to claim 1, wherein the weight ratio of the bioactive material to the polylactic acid in the composite fiber is 0.65 to 1:1.
  4. 根据权利要求1-3中任一项所述的棉花状纤维支架,其中,所述生物活性材料为生物玻璃。The cotton-like fiber scaffold according to any one of claims 1 to 3, wherein the bioactive material is bioglass.
  5. 根据权利要求4所述的棉花状纤维支架,其中,所述生物玻璃为含有二氧化硅、氧化钙、五氧化二磷和添加物的生物玻璃,其中,所述添加物为氧化钠、氧化钾、氧化镁、氧化铝和氟化钙中的任意一种或至少两种的混合物。The cotton-like fiber scaffold according to claim 4, wherein the bioglass is a bioglass containing silicon dioxide, calcium oxide, phosphorus pentoxide and additives, wherein the additives are sodium oxide, potassium oxide , Any one or a mixture of at least two of magnesium oxide, aluminum oxide and calcium fluoride.
  6. 根据权利要求4所述的棉花状纤维支架,其中,所述生物玻璃为45S5型、AW型、Bioverit型、Ceravital型和58S型生物玻璃中的任意一种或至少两种的混合物。The cotton-like fiber scaffold according to claim 4, wherein the bioglass is any one or a mixture of at least two of 45S5 type, AW type, Bioverit type, Ceravital type and 58S type bioglass.
  7. 根据权利要求4所述的棉花状纤维支架,其中,所述生物玻璃经过球磨处理,粒径为0.5~30μm。The cotton-like fiber scaffold according to claim 4, wherein the bioglass is ball milled and has a particle size of 0.5-30 μm.
  8. 根据权利要求1~7中任一项所述的棉花状纤维支架,其中,所述复合纤维的直径为1~50μm。The cotton-like fiber scaffold according to any one of claims 1 to 7, wherein the diameter of the composite fiber is 1 to 50 μm.
  9. 根据权利要求1~8中任一项所述的棉花状纤维支架,其中,所述聚乳酸的数均分子量为100000~1000000。The cotton-like fiber scaffold according to any one of claims 1 to 8, wherein the number average molecular weight of the polylactic acid is 100,000 to 1,000,000.
  10. 一种如权利要求1~9中任一项所述的棉花状纤维支架的制备方法,其 包括如下步骤:A method for preparing the cotton-like fiber scaffold according to any one of claims 1-9, which comprises the following steps:
    步骤(1):将生物活性材料与聚乳酸混合,混合物用有机溶剂溶解,得到纺丝原液;Step (1): mixing the bioactive material with polylactic acid, and dissolving the mixture with an organic solvent to obtain a spinning dope;
    步骤(2):使用静电纺丝设备对步骤(1)中得到的纺丝原液进行静电纺丝,静电纺丝产物用醇类收集;以及Step (2): Electrospin the spinning dope obtained in step (1) using an electrostatic spinning device, and collect the electrostatic spinning product with alcohol; and
    步骤(3):取出步骤(2)的醇类中的凝固后的复合纤维丝,将其干燥后即得到所述棉花状纤维支架。Step (3): Take out the coagulated composite fiber filaments in the alcohol of step (2), and dry them to obtain the cotton-like fiber scaffold.
  11. 根据权利要求10所述的制备方法,其中,步骤(1)中所述的有机溶剂为氯仿;并且The preparation method according to claim 10, wherein the organic solvent in step (1) is chloroform; and
    按重量百分数计算,步骤(1)中所述的纺丝原液中聚乳酸的含量为8~14wt%。Calculated by weight percentage, the content of polylactic acid in the spinning dope described in step (1) is 8-14 wt%.
  12. 根据权利要求10或11所述的制备方法,其中,步骤(2)中所述静电纺丝过程中,静电纺丝设备中纺丝原液的挤出速度为0.05~0.4mL/min;The preparation method according to claim 10 or 11, wherein, in the electrospinning process in step (2), the extrusion speed of the spinning dope in the electrospinning equipment is 0.05 to 0.4 mL/min;
    步骤(2)中所述静电纺丝的电压为10~30kV;The voltage of the electrospinning in step (2) is 10-30kV;
    步骤(2)中所述的静电纺丝设备中,纺丝喷嘴与纺丝接收设备之间的距离为5~30cm;并且In the electrostatic spinning device described in step (2), the distance between the spinning nozzle and the spinning receiving device is 5 to 30 cm; and
    步骤(2)中所述的醇类为乙醇。The alcohol mentioned in step (2) is ethanol.
  13. 根据权利要求10-12中任一项所述的制备方法,其中,步骤(3)中所述的干燥在通风橱中进行;并且The preparation method according to any one of claims 10-12, wherein the drying in step (3) is performed in a fume hood; and
    步骤(3)中所述干燥的温度为室温,干燥的时间为24~48h。The drying temperature in step (3) is room temperature, and the drying time is 24 to 48 hours.
  14. 根据权利要求10-13中任一项所述的制备方法,其中,所述制备方法包括如下步骤:The preparation method according to any one of claims 10-13, wherein the preparation method comprises the following steps:
    步骤(1):将生物玻璃与乙醇混合,混合物经过球磨处理,经干燥、筛分, 得到粒径为0.5~30μm的预处理后的生物玻璃,之后将预处理后的生物玻璃与聚乳酸按重量比0.4~1.5:1混合,混合物用氯仿溶解,得到聚乳酸含量为8~14wt%的纺丝原液;Step (1): The bioglass is mixed with ethanol, the mixture is ball milled, dried and sieved to obtain pretreated bioglass with a particle size of 0.5-30μm, and then press the pretreated bioglass with polylactic acid Mix at a weight ratio of 0.4 to 1.5:1, and dissolve the mixture with chloroform to obtain a spinning dope with a polylactic acid content of 8 to 14 wt%;
    步骤(2):将步骤(1)中得到的纺丝原液注入静电纺丝设备的注射器中,控制静电纺丝设备的电压为10~30kV,注射器以0.05~0.4mL/min的挤出速度挤出纺丝原液,纺丝喷嘴与纺丝接收设备之间的距离为5~30cm,纺丝接收设备中填充有无水乙醇,用于收集静电纺丝的产物;以及Step (2): Inject the spinning stock solution obtained in step (1) into the syringe of the electrospinning equipment, and control the voltage of the electrospinning equipment to 10-30kV, and the syringe will extrude at an extrusion speed of 0.05-0.4mL/min The spinning dope is output, the distance between the spinning nozzle and the spinning receiving device is 5-30cm, and the spinning receiving device is filled with absolute ethanol to collect the product of electrospinning; and
    步骤(3):取出步骤(2)中收集到的凝固在纺丝接收设备中的无水乙醇中的复合纤维丝,将其转移至通风橱中,在室温下干燥24~48h,干燥后即得到所述棉花状纤维支架。Step (3): Take out the composite fiber filaments coagulated in absolute ethanol in the spinning receiving equipment collected in step (2), transfer them to a fume hood, and dry them at room temperature for 24 to 48 hours. The cotton-like fiber scaffold is obtained.
  15. 如权利要求1~9中任一项所述的棉花状纤维支架在骨修复或牙齿硬组织修复领域中的应用。Application of the cotton-like fiber scaffold according to any one of claims 1 to 9 in the field of bone repair or tooth hard tissue repair.
PCT/CN2019/110974 2019-01-25 2019-10-14 Cotton-like fiber scaffold as well as preparation method therefor and application thereof WO2020151261A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910073477.5 2019-01-25
CN201910073477.5A CN109594195B (en) 2019-01-25 2019-01-25 Cotton-shaped fiber scaffold and preparation method and application thereof

Publications (1)

Publication Number Publication Date
WO2020151261A1 true WO2020151261A1 (en) 2020-07-30

Family

ID=65966559

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/110974 WO2020151261A1 (en) 2019-01-25 2019-10-14 Cotton-like fiber scaffold as well as preparation method therefor and application thereof

Country Status (2)

Country Link
CN (1) CN109594195B (en)
WO (1) WO2020151261A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112144176A (en) * 2020-09-01 2020-12-29 郑州大学 Method for producing porous three-dimensional material by enzymatic degradation of PCL/PLLA polymer
CN114575037A (en) * 2022-03-09 2022-06-03 诺一迈尔(苏州)生命科技有限公司 Electrostatic spinning nanofiber membrane and preparation method thereof
CN115748239A (en) * 2022-12-08 2023-03-07 山东大学 Preparation method of high-strength and flexible hydroxyapatite-coated silicon dioxide composite fiber membrane

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109594195B (en) * 2019-01-25 2021-11-05 蓝怡科技集团股份有限公司 Cotton-shaped fiber scaffold and preparation method and application thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060204539A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Electrospun cell matrices
CN101172164A (en) * 2006-11-03 2008-05-07 中国科学院化学研究所 Biopolymer nano tunica fibrosa material capable of being biological degraded and absorbed, preparing method and uses of the same
CN101387015A (en) * 2008-10-24 2009-03-18 暨南大学 Method for preparing polylactic acid nano fiber
GB2484319A (en) * 2010-10-06 2012-04-11 Univ Bolton Electrospinning fibres comprising honey and biocompatible polymer
CN102499997A (en) * 2011-12-27 2012-06-20 吉林大学 Composite nano fiber support material, as well as preparation method and application in bone repairing aspect
CN104120500A (en) * 2013-04-23 2014-10-29 上海交通大学医学院附属第九人民医院 Fish collagen/mesoporous bioglass composite nanofiber membrane and making method thereof
CN105126175A (en) * 2015-09-10 2015-12-09 南方医科大学南方医院 Electrostatic spinning fiber periodontal tissue regeneration material capable of carrying medicine and production method thereof
CN108289975A (en) * 2016-04-28 2018-07-17 国立大学法人名古屋工业大学 The method for manufacturing the bone-regeneration material containing Biodegradable fibers with method of electrostatic spinning
CN109594195A (en) * 2019-01-25 2019-04-09 蓝怡科技集团股份有限公司 A kind of cotton shape fibrous framework and its preparation method and application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002358639A1 (en) * 2001-12-10 2003-06-23 Tech-Medical S.R.L. Biocompatible composite material with an osteotropic action
CN101642589A (en) * 2009-09-11 2010-02-10 华南理工大学 Preparation method of biological active glass/chitosan composite porous support material
CN102432180A (en) * 2011-09-28 2012-05-02 华南理工大学 Method for preparing bioactive glass ceramic material for bone defect restoration
CN102772830B (en) * 2012-07-23 2014-08-06 中国人民解放军第四军医大学 Absorbable composite biomaterial and preparation method thereof
US20180154048A1 (en) * 2016-12-07 2018-06-07 Board Of Trustees Of The University Of Arkansas Tunable porous 3d biodegradable, biocompatible polymer/nanomaterial scaffolds, and fabricating methods and applications of same
CN107158471A (en) * 2017-05-31 2017-09-15 合肥创沃科技有限公司 A kind of preparation method of golden cypress compound bio glass tissue repair materials
CN106983910A (en) * 2017-05-31 2017-07-28 合肥创沃科技有限公司 A kind of preparation method of polylactic acid composite biological glass tissue repair materials
CN107875455A (en) * 2017-10-23 2018-04-06 广州润虹医药科技股份有限公司 A kind of organic-inorganic blending electrospun fibers and preparation method thereof
CN109157678A (en) * 2018-08-31 2019-01-08 杭州卫达生物材料科技有限公司 A kind of filling material of bone and preparation method thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060204539A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Electrospun cell matrices
CN101172164A (en) * 2006-11-03 2008-05-07 中国科学院化学研究所 Biopolymer nano tunica fibrosa material capable of being biological degraded and absorbed, preparing method and uses of the same
CN101387015A (en) * 2008-10-24 2009-03-18 暨南大学 Method for preparing polylactic acid nano fiber
GB2484319A (en) * 2010-10-06 2012-04-11 Univ Bolton Electrospinning fibres comprising honey and biocompatible polymer
CN102499997A (en) * 2011-12-27 2012-06-20 吉林大学 Composite nano fiber support material, as well as preparation method and application in bone repairing aspect
CN104120500A (en) * 2013-04-23 2014-10-29 上海交通大学医学院附属第九人民医院 Fish collagen/mesoporous bioglass composite nanofiber membrane and making method thereof
CN105126175A (en) * 2015-09-10 2015-12-09 南方医科大学南方医院 Electrostatic spinning fiber periodontal tissue regeneration material capable of carrying medicine and production method thereof
CN108289975A (en) * 2016-04-28 2018-07-17 国立大学法人名古屋工业大学 The method for manufacturing the bone-regeneration material containing Biodegradable fibers with method of electrostatic spinning
CN109594195A (en) * 2019-01-25 2019-04-09 蓝怡科技集团股份有限公司 A kind of cotton shape fibrous framework and its preparation method and application

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112144176A (en) * 2020-09-01 2020-12-29 郑州大学 Method for producing porous three-dimensional material by enzymatic degradation of PCL/PLLA polymer
CN114575037A (en) * 2022-03-09 2022-06-03 诺一迈尔(苏州)生命科技有限公司 Electrostatic spinning nanofiber membrane and preparation method thereof
CN115748239A (en) * 2022-12-08 2023-03-07 山东大学 Preparation method of high-strength and flexible hydroxyapatite-coated silicon dioxide composite fiber membrane

Also Published As

Publication number Publication date
CN109594195A (en) 2019-04-09
CN109594195B (en) 2021-11-05

Similar Documents

Publication Publication Date Title
WO2020151261A1 (en) Cotton-like fiber scaffold as well as preparation method therefor and application thereof
Levengood et al. Chitosan-based scaffolds for bone tissue engineering
Fu et al. In vivo biocompatibility and osteogenesis of electrospun poly (ε-caprolactone)–poly (ethylene glycol)–poly (ε-caprolactone)/nano-hydroxyapatite composite scaffold
Mohamadi et al. Electrospun nerve guide scaffold of poly (ε‐caprolactone)/collagen/nanobioglass: an in vitro study in peripheral nerve tissue engineering
Xu et al. Accurately shaped tooth bud cell–derived mineralized tissue formation on silk scaffolds
Karuppuswamy et al. Functionalized hybrid nanofibers to mimic native ECM for tissue engineering applications
US11696974B2 (en) Method for preparing a functionally gradient material for guided periodontal hard and soft tissue regeneration
CN109999227B (en) Preparation method and application of silk fibroin and chitin-based blended nanofiber embedded hydrogel cartilage bionic scaffold
Dehnavi et al. Systematically engineered electrospun conduit based on PGA/collagen/bioglass nanocomposites: The evaluation of morphological, mechanical, and bio‐properties
CN109876186B (en) Biomedical degradable double-layer stent for nerve repair and preparation method thereof
WO2007018165A1 (en) Sponge-like structural body or powder, and process for production thereof
CN112190771A (en) Bone tissue regeneration guide membrane and preparation method thereof
Rowe et al. Dimensionally stable and bioactive membrane for guided bone regeneration: An in vitro study
CN112088021A (en) Novel electrospun synthetic dental barrier membranes for guided tissue regeneration and guided bone regeneration applications
CN106390208A (en) Three-dimensional support material containing hierarchical porous structures and preparation and application
US20190203038A1 (en) Composition with polymer and ceramic and methods of use thereof
Liverani et al. Nanofiber composites in bone tissue engineering
Ramirez Cellulose Nanocrystals Reinforced Electrospun Poly (lactic acid) Fibers as Potential Scaffold for Bone Tissure Engineering.
CN114129778B (en) Method for preparing guided tissue regeneration membrane by combining electrostatic spinning and electrostatic spraying
CN112546299B (en) 3D-printed artificial periosteum, artificial bone, artificial skeleton and preparation method thereof
Faraji et al. Effect of zeolite and zeolite/collagen nanocomposite scaffolds on healing of segmental femur bone defect in rabbits.
Pattanayak et al. Advancing strategies towards the development of tissue engineering scaffolds: a review
US11046823B2 (en) Composition with polymer and ceramic and methods of use thereof
Liu et al. Improvement of mechanical properties of zein porous scaffold by quenching/electrospun fiber reinforcement
Rana et al. Ceramic nanofiber composites

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19912076

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19912076

Country of ref document: EP

Kind code of ref document: A1